← All trials
NCT04517162
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 19, 2020
- Primary completion
- Feb 19, 2021
- Completion date
- Jun 19, 2021
- First posted
- Aug 18, 2020
- Last posted
- Sep 3, 2020
- Enrollment
- 90
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Instituto Nacional de la Nutrición Salvador ZubiranLead sponsor
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranSponsor investigator
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranOverall official - principal investigator
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranStudy chair
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.